How can a natural biological evolution with so many consequences get relatively little attention from research and practice?
Troy Trygstad, PharmD, MBA, PhD
Advertisement
Troy Trygstad, PharmD, PhD, MBA, is the executive director of CPESN USA, a clinically integrated network of more than 3500 participating pharmacies. He received his PharmD and MBA degrees from Drake University and a PhD in pharmaceutical outcomes and policy from the University of North Carolina. He has recently served on the board of directors for the Pharmacy Quality Alliance and the American Pharmacists Association Foundation. He also proudly practiced in community pharmacies across the state of North Carolina for 17 years.
Articles by Troy Trygstad, PharmD, MBA, PhD
The Latest Kaiser Family Foundation Employer Health Benefits Survey Has Unsurprising but Consequential Findings
Believe it or not, none of them are pharmacy specific.
Influenza Vaccination Preparation Should Be on the Docket for Any Pharmacy After a Much-Anticipated ACIP Meeting
The opportunity to optimize all medications, not just those that require a prescription, is long overdue.
Throughout a new graduate’s career, that provider status will become mainstream.
A new technology paradigm is rapidly emerging that is the result of the combined effects of 2 trends: increasing consumerism and payment reform.
Advertisement
Latest Updated Articles
We Can Do Better: Educating on Perimenopause and Menopause Is a Good ThingPublished: November 17th 2025 | Updated:
- Bye-Bye Bubble: Information Technology Puts Pharmacists at Risk of (Gasp!) Interacting with Patient-Centered Care Teams
Published: August 20th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
3
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
4
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
5
